TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ATAI

AtaiBeckley Inc.

Healthcare · Biotechnology

7.40$ +0.0% vs. previous close Closing price · As of: Sep 11, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ATAI
Line item 2019 2020 2021 2022 2023 2024 2025
– 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– 0.1% 0.2% 72.1% 101.6% 153.6% 24.7%
– -0.1% 99.8% 27.9% -1.6% -53.6% 75.3%
– 117.8% 235.1% 31,821.9% 19,708.3% 17,851.3% 1,297.7%
– 406.1% 455.2% 29,892.7% 19,484.4% 14,714.3% 1,591.8%
– 523.8% 690.3% 62,015.0% 39,957.3% 33,287.7% 2,515.0%
– -524.0% -590.5% -61,987.1% -39,958.9% -33,341.2% -2,439.7%
– 357.4% 328.4% 396.1% 845.9% 1,014.3% 28.4%
– -897.0% -874.7% -64,887.6% -13,655.7% -49,003.2% -16,137.2%
– 1.5% -19.6% 2,673.4% 323.6% -286.0% 7.3%
– -854.3% -823.6% -65,401.3% -12,810.2% -48,464.0% -16,142.0%
– -523.8% -874.5% -64,419.3% -12,708.3% -47,835.4% -16,084.0%

Data as of: September 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?